4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-23-018482
Options or other derivatives
- PRESIDENT & CEO acquired 380,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| MORTIMER IAN PRESIDENT & CEO | 2023-03-10 | Grant or award · Stock Option (Right to Buy) | +380,000 | 380,000 | D | ||
Loading xslF345X03/doc4.xml…